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Perchlorate is an inorganic anion used for a
variety of products such as road flares, explo-
sives, pyrotechnics, and solid rocket propel-
lant (Mendiratta et al. 1996). Perchlorate can
also form naturally in the atmosphere, leading
to trace levels of perchlorate in precipitation
(Dasgupta et al. 2005). Natural processes are
considered to concentrate perchlorate in some
locations such as regions of west Texas
(Dasgupta et al. 2005) and northern Chile
(Urbansky et al. 2001). A combination of
human activities and natural sources has led
to the widespread presence of perchlorate in
the environment. As of November 2005, per-
chlorate was detected in drinking water sam-
ples from 4.1% of community water supplies
in 26 different states, with levels ranging from
the method detection limit of 4 µg/L to a
maximum at 420 µg/L [U.S. Environmental
Protection Agency (EPA) 2005]. Most of this
drinking-water contamination is likely due to
contaminated source waters, although in rare
instances perchlorate formation has been
reported to occur in water distribution sys-
tems (Jackson et al. 2004). Additionally, per-
chlorate exposure from the diet is probable
because of the contamination of milk (Kirk
et al. 2005), vegetables (Sanchez et al. 2005),
fruit (Sanchez et al. 2006a), grain (Sanchez
et al. 2006b), and forage crops (Jackson et al.
2005). Perchlorate contamination has also
been reported in dietary supplements and fla-
vor enhancers (Snyder et al. 2006).
Trace levels of perchlorate in the environ-
ment leads to human exposure. Direct meas-
urement of perchlorate in biological samples
collected from people [National Research
Council (NRC) 2005] is considered an excel-
lent assessment of their exposure. We recently
assessed perchlorate exposure in a nationally
representative sample of 2,820 U.S. residents,
≥ 6 years of age, who participated in the
National Health and Nutrition Examination
Survey (NHANES) during 2001 and 2002
(Blount et al. 2006).
Environmental perchlorate exposure is of
potential health concern because much larger
doses of perchlorate have been shown to com-
petitively inhibit iodide uptake (Greer et al.
2002; Wyngaarden et al. 1953). Populations
with low intake of iodine or increased demand
for iodine may be more vulnerable to inhibi-
tion of iodide uptake. Sustained inhibition of
iodide uptake can lead to hypothyroidism,
although perchlorate-induced changes to thy-
roid function have not been previously
demonstrated in any human population
exposed to perchlorate, even at doses as high
as 0.5 mg/kg body weight per day (NRC
2005). The thyroid plays a crucial role in
energy homeostasis and neurologic develop-
ment. Hypothyroidism can lead to metabolic
problems in adults and abnormal development
during gestation and infancy (Braverman and
Utiger 2000). Severe hypothyroidism due to
iodine deficiency during pregnancy is a pre-
ventable cause of cretinism, a permanent cog-
nitive impairment of the developing fetus
(Glinoer 2000). Mild hypothyroidism during
pregnancy has been associated with subtle cog-
nitive deficits in children (Haddow et al. 1999;
Klein et al. 2001), leading the NRC to recom-
mend that consideration be given to adding
iodide to all prenatal vitamins (NRC 2005).
Therefore, we examined relationships between
urinary perchlorate and serum thyroid hor-
mones in men and women, ≥ 12 years of age,
who participated in NHANES 2001–2002.
Subjects and Methods
Study design. NHANES is conducted by the
National Center for Health Statistics of the
Centers for Disease Control and Prevention
(CDC). This survey is designed to assess the
health and nutrition status of the civilian, non-
institutionalized U.S. population. NHANES
uses a complex multistage probability sampling
designed to be representative of the U.S. popu-
lation based on age, sex, race/ethnicity, and
income. Data reported in the present study
were collected using an extensive household
interview addressing health conditions and
health-related behaviors and a standardized
physical examination including medical
blood and urine tests, which were conducted
in mobile examination centers. NHANES
2001–2002 was conducted in 30 locations
throughout the United States. Overall, the
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BACKGROUND: Perchlorate is commonly found in the environment and known to inhibit thyroid
function at high doses. Assessing the potential effect of low-level exposure to perchlorate on thyroid
function is an area of ongoing research.
OBJECTIVES: We evaluated the potential relationship between urinary levels of perchlorate and
serum levels of thyroid stimulating hormone (TSH) and total thyroxine (T4) in 2,299 men and
women, ≥ 12 years of age, participating in the National Health and Nutrition Examination Survey
(NHANES) during 2001–2002. 
METHODS: We used multiple regression models of T4 and TSH that included perchlorate and
covariates known to be or likely to be associated with T4 or TSH levels: age, race/ethnicity, body
mass index, estrogen use, menopausal status, pregnancy status, premenarche status, serum C-reac-
tive protein, serum albumin, serum cotinine, hours of fasting, urinary thiocyanate, urinary nitrate,
and selected medication groups. 
RESULTS: Perchlorate was not a significant predictor of T4 or TSH levels in men. For women over-
all, perchlorate was a significant predictor of both T4 and TSH. For women with urinary iodine
< 100 µg/L, perchlorate was a significant negative predictor of T4 (p < 0.0001) and a positive pre-
dictor of TSH (p = 0.001). For women with urinary iodine ≥ 100 µg/L, perchlorate was a signifi-
cant positive predictor of TSH (p = 0.025) but not T4 (p = 0.550). 
CONCLUSIONS: These associations of perchlorate with T4 and TSH are coherent in direction and
independent of other variables known to affect thyroid function, but are present at perchlorate
exposure levels that were unanticipated based on previous studies.
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survey interview response rate was 83.9% and
the exam response rate was 79.6%. A full
description of the NHANES survey is available
on the NHANES website (CDC 2004). The
study protocol was reviewed and approved by
the CDC institutional review board; addition-
ally, informed written consent was obtained
from all subjects before they took part in the
study. 
Urinary perchlorate levels were measured
by the Division of Laboratory Sciences,
National Center for Environmental Health, on
a representative random one-third subsample
consisting of 2,820 study participants (males
and females), ≥ 6 years of age (Blount et al.
2006). For ages ≥ 12 years, 2,517 persons were
in the random subsample. Serum levels of thy-
roid stimulating hormone (TSH) and total
thyroxine (T4) were only available for 2,299
participants ≥ 12 years of age. 
Demographic variables. Sociodemographic
data were self-reported by study participants.
Race/ethnicity was derived from self-reported
questionnaire data and categorized as non-
Hispanic white, non-Hispanic black, Mexican
American, and “other.” Each of these race/
ethnicity categories was used in the regression
modeling. Non-Hispanic whites were used as
the referent group in regression analysis.
Laboratory methods. During the physical
examinations, whole blood and spot urine
specimens were collected from participants,
aliquoted, and stored cold (2–4°C) or frozen
until shipment. Whole blood was collected
into a red-top 15-mL Vacutainer tube, mixed,
allowed to clot 30–45 min, and centrifuged;
approximately 1 mL serum was stored frozen
in a cryovial for future analysis for TSH and
T4. Serum samples collected in 2001 were
assayed for TSH and T4 by the Coulston
Foundation (Alamogordo, NM) using a
microparticle enzyme immunoassay for the
quantitative determination of TSH, and a
Hitachi 704 chemistry analyzer (Hitachi
Chemical Diagnostics, Mountain View, CA)
for the quantitative determination of T4
(CDC 2003). Serum samples collected in
2002 were assayed for TSH and T4 by
Collaborative Laboratory Services (Ottumwa,
IA) using a chemiluminescent immunoassay
(Access Immunoassay System; Beckman
Instruments, Fullerton, CA) (CDC 2003).
The National Center for Health Statistics
evaluated the TSH and T4 data sets from the
two laboratories and determined that the val-
ues are comparable across the 2 years. 
Surplus urine samples from NHANES
2001–2002 were shipped on dry ice to the
Division of Laboratory Sciences and analyzed
for perchlorate, thiocyanate, and nitrate using
ion chromatography tandem mass spectrome-
try (Blount et al., 2006; Valentin-Blasini et al.
2005). These samples were stored frozen
(–70°C) for up to 4 years before perchlorate
analysis. Experiments evaluating storage at
–70°C for > 2 years indicated no changes in
urinary levels of this analyte (Blount et al.
2006). Reported results for all assays met the
division’s quality control and quality assurance
performance criteria for accuracy and preci-
sion [similar to specifications outlined by
Westgard et al. (1981)]. Urine samples from
the same study participants had previously
been analyzed for iodine using inductively
coupled plasma mass spectrometry (Caldwell
et al. 2005). 
Statistical analysis. Initial multiple regres-
sion analysis found perchlorate to be a signifi-
cant predictor of both T4 and log TSH in
women, but perchlorate did not predict either
T4 or log TSH in men (data not shown).
Therefore, we present subsequent analysis
focused on women.
Of the 1,318 women ≥ 12 years of age, 92
had missing TSH and T4 values, leaving 1,226.
Of these 1,226 women, 91 were excluded from
analysis because they reported a history of thy-
roid disease or current use of thyroid medica-
tions, leaving 1,135 women. Of these 1,135
women, 3 had extreme values of T4 and/or
TSH and were excluded. One of these women
had a total T4 of 27 µg/dL and a TSH of
0.04 IU/L. This woman was clearly hyperthy-
roid and thus was excluded from the analysis.
Two other women had very high TSH levels
(43 and 68 IU/L) and were excluded. Of the
remaining 1,132 women, 21 had missing per-
chlorate measurements, leaving a sample size of
1,111 women.
The major design variables for NHANES
are age, sex, race/ethnicity, and income related
to the poverty level. The values of these vari-
ables for the initial 1,318 women and the final
1,111 women, respectively, are as follows:
mean age, 41.6 and 39.8 years; percent non-
Hispanic whites, 70.8% and 69.4%; percent
non-Hispanic blacks, 11.8% and 12.5%; per-
cent Mexican Americans, 7.0% and 7.0%;
and percent below the poverty level, 13.9%
and 14.9%.
We chose covariates for the multiple regres-
sion analyses that are known to be or likely to
be associated with T4 or TSH. We selected a
broad number of covariates to evaluate the
independence of the perchlorate relationship.
These covariates were age, race/ethnicity, body
mass index (BMI), serum albumin, serum coti-
nine (a marker of tobacco smoke exposure),
estimated total caloric intake, pregnancy status,
postmenopausal status, premenarche status,
serum C-reactive protein, hours fasting before
sample collection, urinary thiocyanate, urinary
nitrate, and use of selected medications. 
For these covariates, Table 1 provides
means (or geometric means if lognormally dis-
tributed) for continuous variables, percent in
category for categorical variables, and number
of missing results for each covariate. Thyroid
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Table 1. Means and percent in category for covariates used in the multiple regression, women ≥ 12 years
of age, NHANES 2001–2002.a
No. Arithmetic mean Geometric mean Percent in category
Variable No. missing (95% CI) (95% CI) (95% CI)
Age (years) 1,111 0 39.8 (38.1–41.6)
Fasting (hr) 1,111 0 10.4 (9.85–10.9)
Serum albumin (g/dL) 1,111 0 4.20 (4.17–4.23)
Serum T4 (µg/dL) 1,111 0 8.27 (7.97–8.58)
Total kilocalories (kcal/1,000) 1,072 39 1.93 (1.87–1.99)
BMI 1,075 36 25.8 (25.2–26.5)
Serum cotinine (µg/L) 1,104 7 0.33 (0.23–0.48)
Serum C-reactive protein (mg/dL) 1,111 0 0.16 (0.14–0.18)
Serum TSH (IU/L) 1,111 0 1.36 (1.31–1.42)
Urine creatinine (mg/dL) 1,109 2 81.4 (76.7–86.5)
Urine iodine (µg/L) 1,111 0 126 (115–138)
Urine nitrate (µg/L × 1,000) 1,106 5 38.0 (35.9–40.3)
Urine perchlorate (µg/L) 1,111 0 2.84 (2.54–3.18)
Urine thiocyanate (µg/L × 1,000) 1,104 7 1.20 (1.08–1.33)
Race/ethnicity 
Non-Hispanic white 1,111 0 69.4 (62.9–75.4)
Non-Hispanic black 1,111 0 12.5 (7.49–19.1)
Mexican American 1,111 0 7.02 (5.14–9.34)
Other race 1,111 0 11.1 (7.04–16.3)
Medication usage 
Furosemide 1,111 0 1.99 (1.25–3.01)
Glucocorticoids and androgens 1,111 0 2.23 (1.24–3.67)
Beta-blocker 1,111 0 4.48 (3.34–5.87)
Estrogen 1,111 0 17.1 (13.2–21.7)
Other drug 1,111 0 1.04 (0.52–1.88)
Menopausal or postmenopausal 1,028 83 35.9 (30.1–41.9)
Pregnant 1,111 0 3.84 (2.74–5.21)
Premenarchal 1,019 92 1.06 (0.48–2.02)
CI, confidence interval.
aExcludes women with missing TSH, T4, or perchlorate, women with history of thyroid disease or taking thyroid drugs, and
three women with outlier values of T4 or TSH (see text).
function has been previously reported to vary
with the constitutional variables of age, race,
sex, pregnancy, and menopause (Braverman
and Utiger 2000). Serum cotinine is a marker
of tobacco smoke exposure, and smoking is
associated with altered thyroid function
(Bertelsen and Hegedus 1994). We included
serum C-reactive protein as a marker for
inflammatory conditions that have been asso-
ciated with alterations in thyroid function.
Both total caloric intake [based on a 24-hr
dietary recall survey and a U.S. Department of
Agriculture (USDA) database (Food and
Nutrition Database for Dietary Studies;
USDA 2004)] and BMI are related to thyroid
function, but the interrelationship as to cause
or effect is unclear. 
Serum albumin was included in our analy-
sis as a possible surrogate for T4 serum protein
binding. NHANES 2001–2002 included total
T4 measurements but not free T4 measure-
ments; total T4 varies with the concentrations
of specific binding proteins. Concentrations of
these proteins can change with physiologic state
and health conditions. Free T4 varies less with
such protein concentration changes than does
total T4. Serum albumin accounts for 15–20%
of T4 binding, with thyroid binding protein
and prealbumin (not measured in NHANES)
accounting for the remaining percentage
(Robbins 2000). Thyroid autoantibody meas-
urements were not available for 2001–2002.
For autoantibodies to affect the relationship
between perchlorate and T4 or TSH, presence
of autoantibodies would have to correlate with
perchlorate levels. We have found no such cor-
relation in the literature and we are unaware of
a rationale for such an association. 
Medications known to affect thyroid func-
tion were also considered. As noted above,
women taking medication containing thyroid
hormone (e.g., levothyroxine) or antithyroid
drugs (e.g., methimazole or propylthiouracil)
were excluded. Use of beta-blockers, estrogen
formulations, steroids, and furosemide were
each modeled using an indicator variable in the
regressions. An “other drug” category was also
modeled by an indicator variable. This “other
drug” category consisted of a heterogeneous
group of other medications that have possible
effects on thyroid function, protein binding, or
measurements, including salicylates, dopamin-
ergics, anticonvulsants and barbiturates, nar-
cotic analgesics, androgenic agents, lithium,
and several others (a total of 28 drug codes). 
We included the log of urinary creatinine
in the models to adjust for variable water excre-
tion. A nonlinear relationship was evaluated by
adding the square of the log of perchlorate to
final models, but it was not significant. Models
were also checked for significance of inter-
action terms involving main effects. We exam-
ined partial regression plots to identify any
unduly influential data points; no unduly
influential points were found. Indicator vari-
able coefficients in the models (e.g., for non-
Hispanic blacks) were interpreted as follows:
1 = group member, and 0 = not a group mem-
ber. Urine samples were collected in three ses-
sions of the day from 0800 hours through
2200 hours. Mean perchlorate levels were not
statistically different across sessions (p = 0.49).
We examined univariate statistics and dis-
tribution plots for each dependent and inde-
pendent variable to look for outliers and to
assess the distribution shape. TSH, perchlorate,
cotinine, BMI, urinary thiocyanate, urinary
nitrate, and C-reactive protein were log10-
transformed to normalize their distributions.
Regression models, including log of per-
chlorate as one of the predictor variables, were
constructed separately for thyroxine and log of
TSH. For the initial phase of analysis, we used
ordinary least-squares regression (OLS) (SAS
Proc Reg, version 9.0; SAS Institute, Cary,
NC) and purposefully did not adjust for the
NHANES complex survey design in order to
obtain a broad group of potentially significant
predictor variables. Forward stepwise and
backward elimination procedures were used
on both population-weighted and unweighted
data. The entry p-value for forward elimina-
tion models was 0.10 and the retaining
p-value for backward elimination was 0.10 in
order to identify significant and borderline sig-
nificant predictors. The forward stepwise and
backward elimination approaches produced
models that were generally in good agreement. 
This OLS analysis produced a generous list
of significant and borderline-significant vari-
ables for regression analysis using SUDAAN
(version 9.0.1; Research Triangle Institute,
Research Triangle Park, NC), which provides
an analysis that adjusts for the complex survey
design. SUDAAN regression models were
tested using a manual backward elimination
approach starting with the variables obtained
from the OLS regression modeling. Selected
variables that were excluded in the SUDAAN
backward elimination process were added to
the final model to ensure they were not signifi-
cant. The stability of the perchlorate coeffi-
cient was monitored during the SUDAAN
backward elimination process. 
In the main SUDAAN regression analysis,
we used population weights to represent
women ≥ 12 years of age in the U.S. popula-
tion for the years 2001 and 2002. In addition,
we performed separate regression analyses with
SUDAAN using unweighted data and verified
that regression coefficients were in good agree-
ment with those obtained using population
weights. Reported regression model results in
the tables use the population-weighted analysis.
Women were categorized based on a uri-
nary iodine cut point of 100 µg/L and analyzed
separately. The 100 µg/L cut point was used
based on the World Health Organization
(WHO) definition of sufficient iodine intake
in populations (WHO 1994). The WHO
noted that the prevalence of goiter begins to
increase in populations with median urinary
iodine < 100 µg/L. A urine iodine level of
100 µg/L represents about the 36th percentile
of urinary iodine concentrations in women liv-
ing in the United States (Caldwell et al. 2005).
Women with lower iodine intake could be
more vulnerable to perchlorate’s effects to
impair iodine uptake. From this analysis, the
significance of urinary perchlorate as a predic-
tor of thyroid function in women was found to
be largely determined by women with urinary
iodine < 100 µg/L. Consequently, we report
here results for women divided into groups
based on urinary iodine levels.
Compared to the use of average multiple
spot urine measurements or 24-hr urine speci-
mens, the use of a single spot urine for perchlo-
rate and iodine measurement has more
imprecision in estimating true urine levels
(Andersen et al. 2001). This imprecision is a
source of random error (not bias) and therefore
decreases statistical power to detect an associa-
tion between perchlorate and either TSH or T4
compared to these other urine collection
approaches.
Results 
For all women ≥ 12 years of age, multiple
regression analysis found urinary perchlorate to
be a significant predictor of serum TSH and a
significant predictor of serum T4 (data not
shown). Because low iodine levels had poten-
tial to affect the relationship of perchlorate
with T4 and TSH, women with urinary iodine
< 100 µg/L were analyzed separately from
women with urinary iodine ≥ 100 µg/L.
Results of this analysis are presented in
Tables 2 and 3 for T4 and in Tables 4 and 5
for TSH. 
For women with urinary iodine < 100
µg/L, multiple regression analysis found per-
chlorate to be a significant predictor
(p < 0.0001) of T4 with a coefficient for log
perchlorate of –0.8917. The result  of
regression of T4 on perchlorate and urinary
creatinine without other covariates yielded
a coefficient of –0.8604 (p < 0.0001).
Perchlorate was also a significant predictor
(p = 0.0010) of log TSH with a coefficient of
0.1230. The result of regression of log TSH
on perchlorate and urinary creatinine with-
out other covariates found a coefficient of
0.1117 (p = 0.0031). The signs of these coef-
ficients are coherent, with increased perchlo-
rate associated with less production of T4 and
an increase in TSH to stimulate additional
T4 production. For women with urinary
iodine ≥ 100 µg/L, perchlorate was not a sig-
nificant predictor of T4 (p = 0.5503) but
remained a significant predictor of log TSH
(p = 0.0249). The regression analysis results
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in Tables 2–5 include variables that were bor-
derline significant (0.05 ≤ p < 0.10) to give
ample opportunity for other variables to
explain variance and better evaluate the inde-
pendence of the perchlorate effect. 
Regression results for men (not shown)
indicated that perchlorate was not a signifi-
cant predictor of either T4 or log TSH. This
finding also held when examining men with
urinary iodine levels < 100 µg/L.
From the regression coefficients for women
with urinary iodine < 100 µg/L, we calculated
the predicted effect size (i.e., the change in T4
and TSH) for different levels of perchlorate
exposure. We chose perchlorate levels corre-
sponding to the 5th, 10th, 25th, 50th, 75th,
90th, and 95th percentiles of urinary perchlo-
rate in women ≥ 12 years of age. The mini-
mum and maximum perchlorate values are
observed results for this population sample;
they are not estimates of the 0th and 100th
percentiles for the U.S. population. As such,
they would be expected to change in another
population sample. The effect size was calcu-
lated from the difference between the mini-
mum level of perchlorate measured in women
and the level of perchlorate corresponding to
the specific percentile. For example, the 50th
percentile of urinary perchlorate for women
was 2.9 µg/L and the minimum level was
0.19 µg/L. Increasing exposure from 0.19 µg/L
to 2.9 µg/L would result in a predicted
decrease in T4 of 1.06 µg/dL.
For TSH, one more step is needed in the
calculation. Because TSH was modeled as log
TSH, the change in TSH from a given change
in perchlorate depends on the starting level of
TSH. In our calculations we used the approxi-
mate 50th and 90th percentiles of TSH as
starting points to estimate the predicted per-
chlorate effect size for TSH. Results of these
calculations for T4 and TSH are presented in
Table 6. For comparison, the normal range is
5–12 µg/dL for T4 and 0.3–4.5 IU/L for TSH. 
To search for a threshold for the perchlo-
rate relationship with T4 and TSH, piecewise
regression models (Neter et al. 1985) were fit
to the data. No inflection point was found for
the perchlorate relationship with T4 or TSH.
However, statistical power is limited to detect
such a threshold, if present.
Discussion
Increased urinary perchlorate was associated
with increased TSH and decreased T4 for
women with urinary iodine levels < 100 µg/L, a
group possibly more susceptible to competitive
inhibition of thyroid iodine uptake by perchlo-
rate. The statistically significant associations of
urinary perchlorate with decreased serum T4
and increased serum TSH were consistent with
competitive inhibition of iodide uptake. 
For women with urine iodine ≥ 100 µg/L,
perchlorate was also a statistically significant
predictor for TSH but not for T4. Greater
iodine intake may have diminished the effect
of perchlorate on T4 in these women. The
significant association with TSH, but not
with T4, in this group may be due to the
greater sensitivity of TSH to impairment of
thyroid function; that is, normal T4 levels are
maintained by increasing TSH to compensate
for impaired thyroid function.
Predicted changes in serum TSH and T4
with increasing perchlorate exposure (Table 6)
can span a notable portion of the normal med-
ical range of TSH and T4 values. Compared
with a urine level of 0.19 µg/L, urinary per-
chlorate of 13 µg/L (95th percentile) yields a
predicted decrease in T4 of 1.64 µg/dL. The
normal range for T4 is 5–12 µg/dL. A similar
exposure would increase TSH by 2.12 IU/L
for a woman starting with a TSH level of
3.11 IU/L (90th percentile for TSH in
Blount et al.
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Table 5. Regression of serum TSH on perchlorate and covariates for women ≥ 12 years of age with urine
iodine ≥ 100 µg/L, NHANES 2001–2002.
Independent variables Coefficient SE p-Value
Intercept –0.6948 0.3415 0.0600
Log (urinary perchlorate) 0.1137 0.0506 0.0249
Log (urinary creatinine) –0.1198 0.0910 0.1884
Age in years 0.0025 0.0006 < 0.0001
Log (BMI) 0.4812 0.1346 0.0004
Non-Hispanic blacka –0.1125 0.0335 0.0008
Log (urinary nitrate) 0.1087 0.0591 0.0660
Log (urinary thiocyanate) –0.0816 0.0352 0.0206
Dependent variable: log of serum TSH (n = 697; R2 = 0.145).
aReferent group for race is non-Hispanic white.
Table 2. Regression of serum T4 on perchlorate and covariates for women ≥ 12 years of age with urine
iodine < 100 µg/L, NHANES 2001–2002.
Independent variable Coefficient SE p-Value
Intercept 8.6508 0.5428 < 0.0001
Log (urinary perchlorate) –0.8917 0.1811 < 0.0001
Log (urinary creatinine) 0.6897 0.3338 0.0391
Estrogen use 1.5117 0.4421 0.0007
Log (C-reactive protein) 0.8249 0.1774 < 0.0001
Mexican Americana 0.6296 0.3684 0.0878
Menopause –0.5908 0.2578 0.0221
Pregnant (by test) 0.7389 0.3662 0.0439
Total kilocalorie intake (÷ 1,000) –0.3334 0.1173 0.0046
Premenarche 0.6401 0.2722 0.0189
Dependent variable: serum T4 (n = 348; R2 = 0.240). 
aReferent group for race is non-Hispanic white.
Table 3. Regression of serum T4 on perchlorate and covariates for women ≥ 12 years of age with urine
iodine ≥ 100 µg/L, NHANES 2001–2002.
Independent variables Coefficient SE p-Value
Intercept 10.6652 1.2345 < 0.0001
Log (urinary perchlorate) 0.2203 0.3687 0.5503
Log (urinary creatinine) 1.3138 0.7183 0.0677
Estrogen use 0.8278 0.2722 0.0024
Log (C-reactive protein) 0.5783 0.1247 < 0.0001
Mexican-Americana 0.5763 0.2522 0.0225
Pregnant (by test) 1.6175 0.3334 < 0.0001
Log (urinary nitrate) –1.1215 0.4994 0.0249
Hours of fasting 0.0290 0.0156 0.0630
Dependent variable: serum T4 (n = 724; R2 = 0.149). 
aReferent group for race is non-Hispanic white.
Table 4. Regression of serum TSH on perchlorate and covariates for women ≥ 12 years of age with urine
iodine < 100 µg/L, NHANES 2001–2002.
Independent variables Coefficient SE p-Value
Intercept 0.2654 0.1183 0.0403
Log (urinary perchlorate) 0.1230 0.0373 0.0010
Log (urinary creatinine) –0.0954 0.0761 0.2103
Beta-blocker use 0.1881 0.0595 0.0016
Estrogen use –0.0918 0.0404 0.0233
Premenarche 0.1288 0.0262 < 0.0001
Dependent variable: log of serum TSH (n = 356; R2 =0.061).
women ≥ 12 years of age). The normal range
for TSH is 0.3–4.5 IU/L. Effect size estimates
that start with the 90th percentile of TSH have
more uncertainty than estimates starting with
the 50th percentile because the predicted TSH
levels fall further from the central portions of
the original data. 
The mechanism of perchlorate’s effect is
competitive inhibition of iodide uptake by the
thyroid (Clewell et al. 2004; Wolff 1998).
Based on this mechanism, individuals with less
iodide available to compete with perchlorate
may be more vulnerable to impaired iodide
uptake. Chronically impaired iodide uptake
could lead to changes in serum thyroid hor-
mones, consistent with the increased TSH and
decreased T4 we find associated with increased
perchlorate exposure in women with urinary
iodine < 100 µg/L. The WHO (2004) has
identified median urinary iodine levels
≥ 100 µg/L as indicating sufficient iodine
intake for a population. Based on concerns
about adequate iodine intake, the NRC (2005)
recently recommended that consideration be
given to adding iodine to all prenatal vitamins.
In the present study, perchlorate was not
found to be a significant predictor of T4 or
TSH in men. Previous studies report that
women have a much higher risk of goiter than
do men, especially in populations with mar-
ginal iodine intake (Laurberg et al. 2000). The
increased vulnerability of women may partially
be caused by increased susceptibility to auto-
immune thyroid disease in women, the
increased demands on the thyroid during
pregnancy, or the effect of estrogens on thy-
roid function. Estradiol has been shown to
block TSH-induced sodium/iodide symporter
(NIS) expression in the FRTL5 rat follicular
cell line (Furlanetto et al. 1999). Impaired
NIS expression could lead to reduced ability of
the thyroid follicular cells to import iodide,
and thus an increased vulnerability to NIS-
inhibitors such as perchlorate. Also, estrogens
increase T4-binding globulin and thus increase
the demand for T4 so that free T4 levels can
remain constant. 
Covariates in the regression models pre-
dicted T4 and TSH levels in a manner gener-
ally consistent with previous studies. We
found that estrogen use was a significant,
independent, and positive predictor of T4 in
both low and sufficient iodine models of
women ≥ 12 years of age, but was not a sig-
nificant predictor in either of the TSH mod-
els. Similar to estrogen use, pregnancy was a
significant or borderline significant predictor
of T4 but not TSH. Both estrogen use and
pregnancy raise estrogen levels, increase thy-
roid binding proteins, and increase serum T4
concentrations (Glinoer 1997). Menopause
lowers estrogen levels and was a significant
predictor of T4 in the regression for women
with urinary iodine levels < 100 µg/L. 
In NHANES III (1988–1994), non-
Hispanic blacks were reported to have lower
TSH than other groups, and Mexican
Americans had higher T4 levels than non-
Hispanic blacks and whites (Hollowell et al.
2002). The models for TSH and T4 in the pre-
sent study were consistent with these previous
findings concerning race/ethnicity. Non-
Hispanic blacks have also been shown to have
lower urinary perchlorate levels than non-
Hispanic whites, although the reason for this
difference is not known (Blount et al. 2006).
Age was positively associated with TSH in
women with urinary iodine levels ≥ 100 µg/L,
but not significant for women with urinary
iodine levels < 100 µg/L. A positive association
of age and TSH was seen in NHANES III and
other studies (Canaris et al. 2000; Hollowell
et al. 2002). 
BMI was significant in the TSH model for
women with urinary iodine levels ≥ 100 µg/L,
and total caloric intake was significant in the
T4 model for women with urinary iodine levels
< 100 µg/L. Thyroid function clearly has an
effect on BMI, as seen clinically and docu-
mented in populations (Nyrnes et al. 2006).
The reverse is also true, because BMI and total
caloric intake can influence the hypothalamic–
pituitary–thyroidal axis, although usually at
the extremes of body weight and caloric intake
(Acheson et al. 1984; Burger et al. 1987;
Danforth et al. 1979; Loucks et al. 1992;
Loucks and Heath 1994). Total caloric intake
in NHANES is a 24-hr recall of food intake.
Depending on how well recent intake reflects
long-term intake, total caloric intake may par-
allel the effect of BMI, which was not seen in
the present study. Increased caloric intake is
known to increase thyroid hormone disposi-
tion through deiodination pathways (Burger
et al. 1987; Danforth et al. 1979), increasing
the conversion of T4 to the active form,
triiodothyronine (T3), and increasing conver-
sion of T3 to inactive forms. The effect of
changes in calories and carbohydrate composi-
tion of the diet on thyroid disposition may
have different short- and long-term effects on
T3 and T4 levels. In the present study, hours
of fasting before sample collection was a
borderline significant predictor in one regres-
sion model: T4 in women with sufficient
iodine. Fasting for 60 hr can reduce TSH in
humans, but fasting for shorter periods has
unknown effects on thyroid function. 
Beta-blocker drugs are commonly used to
treat hypertension and other cardiovascular
conditions. Beta-blockers inhibit the conver-
sion of T4 to the more active form, T3, and
increase serum TSH (Kayser et al. 1991). Use
of these drugs was positively associated with
TSH in the regression for women with urinary
iodine < 100 µg/L. Serum C-reactive protein
was positively associated with T4 in women in
each of the iodine groups. C-reactive protein is
an acute phase reactant protein increased in
many inflammatory conditions in response to
production of tissue-generated cytokines, par-
ticularly interleukin-6, and has been used as a
marker for both specific and systemic low-level
inflammation conditions. It is unclear if
C-reactive protein is associated with thyroid
function other than thyroiditis (Jublanc et al.
2004; Pearce et al. 2003; Tuzcu et al. 2005).
However, the stimulus for C-reactive protein,
interleukin-6, has a firm inverse relationship
with serum T3 in nonthyroidal illnesses. Also,
C-reactive protein and serum T4 binding pro-
teins are synthesized by the liver; C-reactive
protein may vary with an unrecognized health
or physiologic condition that affects the syn-
thesis of both proteins. The association of
C-reactive protein and T4 in our study is
unclear.
Other variables that are known to possi-
bly affect thyroid function or measurements
were not significant predictors in the regres-
sion models, including the categories of
medications (other than estrogen use and
beta-blockers), serum albumin, and serum
cotinine. Generally, other medication cate-
gories were small and unlikely to have signifi-
cant effects. Serum albumin did not appear in
the final models. Factors such as estrogen use
that increase protein binding of thyroid hor-
mones may have accounted for variance in T4
due to protein binding that serum albumin
may have otherwise explained. Serum cotinine
is a marker of tobacco smoke exposure, and
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Table 6. Predicted change in serum T4a and serum TSHb levels based on changes in urinary perchlorate
levels in women ≥ 12 years of age, with urine iodine < 100 µg/L, NHANES 2001–2002.
Change in TSH (IU/L)c
Change in Initial TSH of 1.40 IU/L Initial TSH of 3.11 IU/L 
Change in urine perchlorated T4 (µg/dL) (50th TSH percentile) (90th TSH percentile)
0.19 to 0.65 µg/L (5th percentile) 0.48 0.23 0.51
0.19 to 0.92 µg/L (10th percentile) 0.61 0.30 0.67
0.19 to 1.6 µg/L (25th percentile) 0.83 0.42 0.93
0.19 to 2.9 µg/L (50th percentile) 1.06 0.56 1.24
0.19 to 5.2 µg/L (75th percentile) 1.28 0.70 1.56
0.19 to 9.0 µg/L (90th percentile) 1.49 0.85 1.89
0.19 to 13 µg/L (95th percentile) 1.64 0.95 2.12
0.19 to 100 µg/L (maximum) 2.43 1.63 3.61
aNormal range for T4: 5–12 µg/dL. bNormal range for TSH: 0.3–4.5 IU/L. 
cDepends on initial TSH level. dMinimum level
measured, 0.19 µg/L.
smoking is associated with altered thyroid
function (Belin et al. 2004; Bertelsen and
Hegedus 1994). However, tobacco smoke
also contains other factors that can inhibit
TSH secretion (Bartalena et al. 1995), and
perhaps is an explanation for the absence of
an association of serum cotinine with either
TSH or T4. 
Cyanide in tobacco smoke is metabolized
to thiocyanate, a competitive inhibitor of
iodide uptake (Tonacchera et al. 2004). Also,
nitrate from dietary sources and from forma-
tion by intestinal bacteria can compete with
iodide. In vitro studies indicate that perchlo-
rate is a more potent inhibitor of human NIS,
with potencies 15, 30, and 240 times greater
than thiocyanate, iodide, and nitrate, respec-
tively (Tonacchera et al. 2004). Thus, the
ability of NIS to transport adequate amounts
of iodide depends on the relative concentra-
tions of these competing anions. Based on
the relative concentrations of perchlorate,
nitrate, and thiocyanate likely to be found in
human serum, several researchers have pre-
dicted that nitrate and thiocyanate are more
likely than perchlorate to impair thyroid
function (DeGroef et al. 2006; Gibbs 2006).
Thiocyanate-induced NIS inhibition is a
plausible explanation of the association of
smoking with goiter in populations with low
iodine intake (Knudsen et al. 2002) and is
analogous to the association of perchlorate
exposure with thyroid hormone levels
observed in our study. However, in women
with urinary iodine levels ≥ 100 µg/L, urinary
thiocyanate was negatively associated with
serum TSH, a direction unexpected based on
a mechanism of NIS inhibition. The explana-
tion for this is unclear. Urinary nitrate was
negatively associated with serum T4 in
women with urinary iodine levels ≥ 100 µg/L,
a direction consistent with inhibition of NIS.
Goitrogenic effects of nitrate intake in animal
studies have been observed (Wyngaarden
et al. 1953), but there are few studies in
humans.
Recently the NRC (2005) evaluated the
potential health effects of perchlorate inges-
tion. Based on studies of long-term treatment
of hyperthyroidism and clinical studies of
healthy adults, the NRC panel estimated that
a perchlorate dose of > 0.40 mg/kg/day would
be required to cause hypothyroidism in
adults, although lower doses may lead to
hypothyroidism in sensitive subpopulations
(NRC 2005).
Comparison of our results to previous
studies requires consideration of a) target
population group studied, b) estimated dose of
perchlorate, c) duration of exposure to perchlo-
rate dose, and d) sample size (statistical power).
First, for men, we found no relationship with
perchlorate and T4 or TSH. This finding is in
general agreement with predicted effects of this
level of perchlorate exposure based on reported
studies of exposure in men. Lawrence et al.
(2000) administered 10 mg perchlorate daily
(~ 0.14 mg/kg) to iodine-sufficient adult males
for 14 days and found a 10% decrease in radio-
active iodine uptake (RAIU), but with no
change in TSH or free T4.
Greer et al. (2002) administered perchlo-
rate to 16 male and 21 female volunteers for
14 days, and found increasing RAIU inhi-
bition for doses between 0.02 and 0.5
mg/kg/day, with no perchlorate-related change
in TSH or free T4. An unknown number of
women in that study may have had urinary
iodine < 100 µg/L, but if the women were typ-
ical of the U.S. population (Caldwell et al.
2005), the predicted number of women with
low urinary iodine would be 7–8. Braverman
et al. (2006) administered perchlorate to
13 iodine-sufficient male and female volunteers
at daily doses of 0.5 mg and 3 mg for
6 months, and found no change in RAIU,
TSH, or free T4. Two other studies have also
found that workers exposed to perchlorate
intermittently for long periods did not have
significant changes to serum TSH or T4 levels
(Braverman et al. 2005; Lamm et al. 1999).
These study populations were either exclusively
(Braverman et al 2005) or predominantly
(Lamm et al 1999) male. 
For women, only two perchlorate studies
have focused on women or included a large
percentage of women. A recent study of 184
pregnant Chilean women, with mean urinary
perchlorate levels near the 99th percentile for
women in NHANES 2001–2002, found no
perchlorate relationship with thyroid function
(Tellez et al. 2005). Of these 184 women,
181 had mean urinary iodine levels ≥ 100 µg/L
and only 3 had mean levels < 100 µg/L.
Therefore, the results of Tellez et al. (2005)
would compare to the present results for
women with urinary iodine levels ≥ 100 µg/L.
Urinary iodine levels in the Chilean study
population (median 269 µg/L) were higher
than urinary iodine levels found in the
NHANES 2001–2002 population [median
168 µg/L; 95% confidence interval, 159–178
µg/L]. The Chilean women (Tellez et al.
2005) were also pregnant, which increases the
variability in T4 and TSH. This increased
variability would make an association
between perchlorate and thyroid function
harder to find. The second study with a large
percentage of women was Greer et al. (2002)
discussed above. These two studies are com-
pared with the present study in Table 7.
Table 7 indicates that our study is the first
to target and separately analyze results for
women with lower levels of urinary iodine, a
potentially susceptible population. A second
special attribute of the present study is the
much larger sample size of women, affording
more statistical power to detect a potential
effect. By averaging over many women, the
current data likely represents a good approxi-
mation of a population steady-state exposure
to perchlorate that women have had for a long
period of time. If a mid- to long-term expo-
sure is needed for perchlorate to affect thyroid
function, this data would have a better oppor-
tunity to detect that effect than study designs
using short-term exposures. The influence of
duration of exposure merits further study.
Accurate assessment of exposure is critical
to detect biochemical end points potentially
related to exposure. Our laboratory recently
developed an improved method for measuring
urinary perchlorate, which enhances individ-
ual perchlorate exposure assessment (Valentin-
Blasini et al. 2005). The use of this new
urinary perchlorate measurement strengthens
the ability of the present study to detect
potential associations with T4 and TSH.
The present study has the general limita-
tions of a cross-sectional analysis. Therefore,
the relationship between urinary perchlorate
and thyroid function was examined with
attention to the potential influences of chance,
bias, or confounding. Perchlorate (as with any
of the significant predictor variables) could be
a surrogate for another unrecognized determi-
nant of thyroid function. We also assumed in
this analysis that urinary perchlorate correlates
with levels in the thyroid stroma and tissue, a
kinetically distinct compartment. This would
be the case in a population with stable,
chronic exposures, which is likely but not cer-
tain in this population. A large sample size
helps to average such potential kinetic differ-
ences. Finally, a measurement of free T4
would be an improvement to the study. 
Blount et al.
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Table 7. Comparison of perchlorate studies targeting women or including a high percentage of women.
Greer et al. (2002) Tellez et al. (2005) Present study
No. of females studied 21 (37 total subjects) 184 1,111
No. of females with urine Unknown 3a 348, T4 analysis
iodine < 100 µg/L (estimate 7–8) 356, TSH analysis
Females with urine iodine < 100 µg/L No No Yes
analyzed separately
Perchlorate dose and duration Up to 0.5 mg/kg/day Long-term environmental Long-term environmental
of exposure for 14 days exposure exposure
Comments All women pregnant, 
increasing variability
of T4 and TSH
aAverage of one to three spot urine samples.
Conclusions
Urinary perchlorate is associated with an
increased TSH and decreased total T4 in
women ≥ 12 years of age with urine iodine
levels < 100 µg/L in the U.S. population dur-
ing 2001–2002. For women with urine
iodine levels ≥ 100 µg/L, urine perchlorate is
a significant predictor of TSH but not T4.
These effects of perchlorate on T4 and TSH
are coherent in direction and independent of
other variables known to affect thyroid func-
tion, but are found at perchlorate exposure
levels that were unanticipated based on previ-
ous studies. Further research is recommended
to affirm these findings.
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